Fineline Cube

Follow:
14409 Articles
MGI Tech Co., Ltd Partners with Human Cell Atlas Consortium to Advance Cell Mapping
CompanyDeals

MGI Tech Co., Ltd Partners with Human Cell Atlas Consortium to Advance Cell Mapping

AstraZeneca Confirms Executive Vice President Leon Wang's Detention in China
Company

AstraZeneca Confirms Executive Vice President Leon Wang’s Detention in China

Jiangsu Kanion Pharmaceutical to Acquire Xintrum Pharmaceuticals for RMB 270 Million
CompanyDeals

Jiangsu Kanion Pharmaceutical to Acquire Xintrum Pharmaceuticals for RMB 270 Million

Ascletis Pharma's ASC47 Showcases Promising Weight Loss Results in Phase I Clinical Trial
CompanyDrug

Ascletis Pharma’s ASC47 Showcases Promising Weight Loss Results in Phase I Clinical Trial

Nuwacell Biotechnologies Secures RMB150 Million in Series B Financing for iPSC Therapies
CompanyDeals

Nuwacell Biotechnologies Secures RMB150 Million in Series B Financing for iPSC Therapies

Shanghai Henlius Biotech Partners with SVAX to Boost MENAT Region's Access to Biological Drugs
CompanyDeals

Shanghai Henlius Biotech Partners with SVAX to Boost MENAT Region’s Access to Biological Drugs

Johnson & Johnson MedTech's Varipulse Platform Receives FDA Approval for Atrial Fibrillation Treatment
CompanyMedical Device

Johnson & Johnson MedTech’s Varipulse Platform Receives FDA Approval for Atrial Fibrillation Treatment

Sichuan Biokin Pharmaceutical Gets FDA Approval for Phase I Study of BL-M17D1 in Solid Tumors
CompanyDrug

Sichuan Biokin Pharmaceutical Gets FDA Approval for Phase I Study of BL-M17D1 in Solid Tumors

Bayer AG Receives FDA 510(k) Clearance for MEDRAD Centargo CT Injection System
CompanyMedical Device

Bayer AG Receives FDA 510(k) Clearance for MEDRAD Centargo CT Injection System

Sichuan Huiyu Pharmaceutical's HYP-6589 Receives NMPA Approval for Solid Tumor Clinical Trial
CompanyDrug

Sichuan Huiyu Pharmaceutical’s HYP-6589 Receives NMPA Approval for Solid Tumor Clinical Trial

Ascentage Pharma's Lisaftoclax and AceLink Therapeutics' AL01211 Receive FDA Designations
CompanyDrug

Ascentage Pharma’s Lisaftoclax and AceLink Therapeutics’ AL01211 Receive FDA Designations

AskBio's AB-1003 Receives Rare Pediatric Disease and Orphan Drug Designations from FDA
CompanyDrug

AskBio’s AB-1003 Receives Rare Pediatric Disease and Orphan Drug Designations from FDA